CPSH Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap GNK Q1 2026 Earnings Massive EPS Beat Driven by Strong Market Conditions Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage QLYS Q1 2026 Earnings EPS Beats Estimates by 615 as Stock Edges Lower RIOT Q1 2026 Earnings EPS Lags Consensus by Wide Margin Stock Climbs 037 Despite Miss DLO Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Solid Operational Backdrop